AETHLON MEDICAL INC (AEMD)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 03-31. Amounts in USD.

Revenue Quarterly

0 250K 500K 750K Q1 '19: 149.6K Q2 '19: 0 Q3 '19: 0 Q4 '19: 80K Q1 '20: 30K Q2 '20: 0 Q3 '20: 413.5K Q4 '20: 206.7K Q1 '21: 0 Q2 '21: 0 Q3 '21: 624.9K Q4 '21: 34.2K Q1 '22: 132K Q2 '22: 132K Q3 '22: 17.1K Q4 '22: 13.1K Q1 '23: 0 Q2 '23: 0 Q3 '23: 0 Q4 '23: 574.2K Q2 '19 Q1 '20 Q4 '20 Q3 '21 Q2 '22 Q1 '23 Q4 '23

Gross Profit Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income Quarterly

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q2 '22: -2M Q3 '22: -2.5M Q4 '22: -3.8M Q1 '23: -2.9M Q2 '23: -3.7M Q3 '23: -2.8M Q4 '23: -2.5M Q1 '24: -3.4M Q2 '24: -3.2M Q3 '24: -3.6M Q4 '24: -2.5M Q1 '25: -2.6M Q2 '25: -2.9M Q3 '25: -1.8M Q4 '25: -2M Q1 '26: -1.8M Q2 '26: -1.5M Q3 '26: -2.1M Q4 '26: -1.9M Q1 '27: -1.6M Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26 Q1 '27

Net Income Quarterly

-7.5M -5M -2.5M 0 2.5M 5M 7.5M Q2 '22: -2M Q3 '22: -2.5M Q4 '22: -3.8M Q1 '23: -2.9M Q2 '23: -3.8M Q3 '23: -2.8M Q4 '23: -2.5M Q1 '24: -3.3M Q2 '24: -3M Q3 '24: -3.5M Q4 '24: -2.4M Q1 '25: -2.6M Q2 '25: -2.8M Q3 '25: -1.8M Q4 '25: -6.3M Q1 '26: -1.8M Q2 '26: -1.5M Q3 '26: -2M Q4 '26: -1.9M Q1 '27: -1.5M Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26 Q1 '27

Cost of Revenue Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Quarterly

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q2 '22: -1.9M Q3 '22: -2.7M Q4 '22: -3.1M Q1 '23: -2.7M Q2 '23: -2.9M Q3 '23: -2M Q4 '23: -2.9M Q1 '24: -2.5M Q2 '24: -2.7M Q3 '24: -2.4M Q4 '24: -2.6M Q1 '25: -1.7M Q2 '25: -2.2M Q3 '25: -2M Q4 '25: -1.7M Q1 '26: -1.7M Q2 '26: -1.7M Q3 '26: -1.9M Q4 '26: -1.8M Q1 '27: -1.9M Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26 Q1 '27

Free Cash Flow Quarterly

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q3 '21: -2.2M Q4 '21: -2.2M Q1 '22: -2.1M Q2 '22: -1.9M Q3 '22: -2.8M Q4 '22: -3.3M Q1 '23: -2.8M Q2 '23: -3.6M Q3 '23: -2.1M Q4 '23: -3M Q1 '24: -2.7M Q2 '24: -2.7M Q3 '24: -2.4M Q4 '24: -2.6M Q1 '25: -1.7M Q2 '25: -2.2M Q3 '25: -2M Q4 '25: -1.7M Q1 '26: -1.7M Q1 '27: -1.9M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q1 '27

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 90M 180M 270M Q2 '14: 187.6M Q3 '14: 198.2M Q1 '15: 227.1M Q2 '15: 259.4M Q1 '22: 12.8M Q2 '22: 15.4M Q3 '22: 15.4M Q1 '23: 15.5M Q2 '23: 2.1M Q3 '23: 2.3M Q1 '24: 2.4M Q2 '24: 2.5M Q3 '24: 2.5M Q1 '25: 932.2K Q2 '25: 174.2K Q3 '25: 174.5K Q1 '26: 41.5K Q2 '26: 397.5K Q3 '26: 823.1K Q1 '27: 384.7K Q3 '14 Q1 '22 Q1 '23 Q1 '24 Q1 '25 Q1 '26 Q1 '27

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-120.00 -80.00 -40.00 0.00 40.00 80.00 120.00 Q4 '21: -0.65 Q1 '22: -0.66 Q2 '22: -0.64 Q3 '22: -0.60 Q4 '22: -0.70 Q1 '23: -0.73 Q2 '23: -2.44 Q3 '23: -3.52 Q4 '23: -4.29 Q1 '24: -5.45 Q2 '24: -4.83 Q3 '24: -4.96 Q4 '24: -38.86 Q1 '25: -40.27 Q2 '25: -55.16 Q3 '25: -63.84 Q4 '25: -66.34 Q1 '26: -106.00 Q2 '26: -93.63 Q3 '26: -86.03 Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.